Acronym: INDUCT
Obesity significantly reduces health-related quality of life and is considered a major risk factor for serious secondary conditions. In addition to type 2 diabetes mellitus, these primarily include cardiovascular diseases (such as high blood pressure), mental health issues, respiratory diseases and osteoarthritis. Against this backdrop, innovative therapeutic approaches are gaining in importance: current evidence suggests that time-restricted eating (TRE) – a form of intermittent fasting – represents a clinically promising strategy for weight loss.
INDUCT had two key objectives:
In a general practice setting, individuals with obesity (BMI 30–45 kg/m²) were randomised and divided into two groups. The intervention group (IG) fasted for 6 months following the 16:8 regimen (16 consecutive hours without eating, 8 hours for eating), whilst the control group (KG) received standard care at the GP practice. Health metrics, questionnaires and patient diaries were collected before, during and after these 6 months.
The randomised controlled intervention study on obesity was conducted between August 2023 and February 2025, involving 37 general practice research practices. Of the 147 participants initially enrolled, data sets from 123 patients were available for the statistical analysis of the primary endpoint. With regard to the primary endpoint, participants in the intervention arm who undertook intermittent fasting, with missing values imputed, showed an average weight loss of 2.2 % (SD: 6.2 %) of their baseline weight (target: 2.5 % of baseline weight at the end of the intervention). It was found that a higher baseline BMI and older age in the intervention group were significant factors influencing the success of the intervention, whilst gender had no influence; furthermore, adherence proved to be a key predictor.
2025 · Nutrition Journal
Lorena Braun, Hannah Haumann, Andreas Polanc, Roland Koch, Elke Feil, Anika Klein, Claudia Salm, Frank Peters-Klimm, Gudrun Hübner, Christian Thies, Stephanie Biergans, FoPraNet-B. W. Study Group, Stefanie Joos